Literature DB >> 2876110

Hypernephroma associated with multiple endocrine neoplasia type I: a case report.

P S Denker, D Wright, J R Hilscher, S R Saba, G Ramirez.   

Abstract

We report a case of multiple endocrine neoplasia type I and hypernephroma. Parathyroid hyperplasia, adrenocortical hyperplasia, a nodular goiter, multiple lipomas, a chromophobe adenoma of the pituitary and hypernephroma had all been diagnosed previously. All but the last are features consistent with the diagnosis of multiple endocrine neoplasia type I (Wermer's syndrome). The association of multiple endocrine neoplasia type I and hypernephroma may represent a new manifestation of this pleiotropic syndrome.

Entities:  

Mesh:

Year:  1986        PMID: 2876110     DOI: 10.1016/s0022-5347(17)45120-2

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  A Possible New Multiple Endocrine Neoplasia Mutation in a Patient with a Prototypic Multiple Endocrine Neoplasia Presentation.

Authors:  Rino Buzzola; Lilamani Romayne Kurukulasuriya; Mariana Touza; Norman S Litofsky; Stephen Brietzke; James R Sowers
Journal:  Cardiorenal Med       Date:  2016-01-15       Impact factor: 2.041

2.  Lack of allelic loss at the multiple endocrine neoplasia type 1 (MEN-1) gene locus in a pancreatic ductal (non-endocrine) adenocarcinoma of a patient with the MEN-1 syndrome.

Authors:  C Bordi; A Falchetti; C Azzoni; T D'Adda; A Morelli; A Peracchia; M L Brandi
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 3.  Multiple Endocrine Neoplasia: Genetics and Clinical Management.

Authors:  Jeffrey A Norton; Geoffrey Krampitz; Robert T Jensen
Journal:  Surg Oncol Clin N Am       Date:  2015-07-27       Impact factor: 3.495

4.  Causes of death and prognostic factors in multiple endocrine neoplasia type 1: a prospective study: comparison of 106 MEN1/Zollinger-Ellison syndrome patients with 1613 literature MEN1 patients with or without pancreatic endocrine tumors.

Authors:  Tetsuhide Ito; Hisato Igarashi; Hirotsugu Uehara; Marc J Berna; Robert T Jensen
Journal:  Medicine (Baltimore)       Date:  2013-05       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.